https://www.techtransfer.nih.gov/patent/e-047-2022-0-ae-01
Human Monoclonal Antibodies That Broadly Target Coronaviruses | Technology Transfer
human monoclonal antibodiesbroadlytargetcoronavirusestechnology
https://www.techtransfer.nih.gov/patent/e-014-2017-0-fr-01
HUMAN MONOCLONAL ANTIBODIES SPECIFIC FOR FLT3 AND USES THEREOF | Technology Transfer
human monoclonal antibodiesspecific
https://www.techtransfer.nih.gov/patent/e-004-2005-4-au-06
Human Monoclonal Antibodies Against Hendra And Nipah | Technology Transfer
human monoclonal antibodieshendranipahtechnologytransfer
https://www.techtransfer.nih.gov/patent/e-251-2004-0-ca-04
Broadly Cross-Reactive HIV Neutralizing Human Monoclonal Antibodies | Technology Transfer
human monoclonal antibodiesbroadlycrossreactivehiv
https://www.techtransfer.nih.gov/patent/e-047-2022-0-om-01
Human Monoclonal Antibodies That Broadly Target Coronaviruses | Technology Transfer
human monoclonal antibodiesbroadlytargetcoronavirusestechnology
https://www.techtransfer.nih.gov/patent/e-217-2005-1-us-01
Human Monoclonal Antibodies That Specifically Bind IGF-II | Technology Transfer
human monoclonal antibodiesspecificallybindigfii
https://www.thermofisher.com/antibody/product/PDGF-B-Biosimilar-Antibody-Recombinant-Monoclonal/MA5-58371
PDGF-B (Biosimilar) Recombinant Human Monoclonal Antibody | Invitrogen (MA5-58371)
Detect PDGF-B (Biosimilar) in ELISA, Flow, Functional, SPR. Reacts with Human. Catalog # MA5-58371
human monoclonalpdgfbinvitrogen
https://www.techtransfer.nih.gov/patent/e-162-2014-0-it-24
HUMAN MONOCLONAL ANTIBODIES AGAINST EPHA4 AND THEIR USE | Technology Transfer
human monoclonal antibodiesusetechnologytransfer
https://www.techtransfer.nih.gov/patent/e-014-2017-0-gb-01
HUMAN MONOCLONAL ANTIBODIES SPECIFIC FOR FLT3 AND USES THEREOF | Technology Transfer
human monoclonal antibodiesspecific
https://www.techtransfer.nih.gov/patent/e-004-2005-4-us-07
Human Monoclonal Antibodies Against Hendra And Nipah | Technology Transfer
human monoclonal antibodieshendranipahtechnologytransfer
https://www.techtransfer.nih.gov/patent/e-130-2011-0-fr-18
Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof | Technology Transfer
human monoclonal antibodies
https://www.techtransfer.nih.gov/patent/e-130-2011-0-pct-02
Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof | Technology Transfer
human monoclonal antibodies
https://pubchem.ncbi.nlm.nih.gov/patent/EP-0105804-B1
Human monoclonal antibodies against bacterial toxins - Patent EP-0105804-B1 - PubChem
EP-0105804-B1 chemical patent summary.
human monoclonal antibodiesbacterial toxins
https://www.semanticscholar.org/topic/Anti-VEGFR-2-Fully-Human-Monoclonal-Antibody/10822061
Anti-VEGFR-2 Fully Human Monoclonal Antibody IMC-1121B | Semantic Scholar
human monoclonalantivegfrfully
https://www.techtransfer.nih.gov/patent/e-438-1986-0-us-01
PREPARATION OF HUMAN MONOCLONAL ANTIBODIES OF SELECTIED SPECIFICITY AND ISOTYPES | Technology...
human monoclonal antibodiespreparationspecificityisotypestechnology
https://www.techtransfer.nih.gov/patent/e-004-2005-0-us-01
Human Monoclonal Antibodies Against Hendra And Hipah Viruses | Technology Transfer
human monoclonal antibodieshendravirusestechnologytransfer
https://www.techtransfer.nih.gov/patent/e-004-2005-1-us-01
Human Monoclonal Antibodies Against Hendra And Hipah. | Technology Transfer
human monoclonal antibodieshendratechnologytransfer
https://pubmed.ncbi.nlm.nih.gov/41087744/
Cross-neutralizing and potent human monoclonal antibodies against historical and emerging H5Nx...
Highly pathogenic avian influenza H5Nx viruses are an emerging threat for global health, especially clade 2.3.4.4b H5N1 virus which causes panzootic...
human monoclonal antibodiescrossneutralizingpotent
https://www.techtransfer.nih.gov/patent/e-162-2014-0-ch-11
HUMAN MONOCLONAL ANTIBODIES AGAINST EPHA4 AND THEIR USE | Technology Transfer
human monoclonal antibodiesusetechnologytransfer
https://pubmed.ncbi.nlm.nih.gov/33804519/
Isolation and Characterization of Cross-Reactive Human Monoclonal Antibodies That Potently...
Australian bat lyssavirus (ABLV) is a rhabdovirus that circulates in four species of pteropid bats (ABLVp) and the yellow-bellied sheath-tailed bat (ABLVs) in...
human monoclonal antibodiesisolationcharacterizationcross
https://www.thermofisher.com/antibody/product/PCSK9-Alirocumab-Biosimilar-Antibody-Recombinant-Monoclonal/MA5-41963
PCSK9 (Alirocumab Biosimilar) Recombinant Human Monoclonal Antibody | Invitrogen (MA5-41963)
Detect PCSK9 (Alirocumab Biosimilar) in ELISA, Flow, Functional, SPR. Reacts with Human. Catalog # MA5-41963
human monoclonalalirocumabbiosimilarrecombinantantibody
https://www.techtransfer.nih.gov/patent/e-091-2009-0-us-01
Human Monoclonal Antibody Variable Fragments (Fvs) To Mesothelin | Technology Transfer
human monoclonalantibodyvariablefragmentsfvs
https://pubchem.ncbi.nlm.nih.gov/patent/EP-0672120-B1
Production of human monoclonal antibodies active against hepatitis b surface antigen - Patent...
EP-0672120-B1 chemical patent summary.
hepatitis b surface antigenhuman monoclonal antibodies
https://www.news-medical.net/news/2004/06/07/2245.aspx
Experimental human monoclonal antibody shows striking benefit in patients with advanced melanoma
Jun 7, 2004 - Early testing of an experimental human monoclonal antibody showed a striking benefit in patients with advanced melanoma, say researchers at The University of...
human monoclonal
https://www.techtransfer.nih.gov/patent/e-188-2010-1-us-02
Human Monoclonal Antibody Against Human Folate Receptor Beta | Technology Transfer
human monoclonalantibodyfolatereceptorbeta
https://www.techtransfer.nih.gov/patent/e-030-2021-0-pct-02
HUMAN MONOCLONAL ANTIBODIES TARGETING SARS-COV-2 | Technology Transfer
human monoclonal antibodiessars covtargetingtechnologytransfer
https://www.techtransfer.nih.gov/patent/e-004-2005-4-pct-01
Human Monoclonal Antibodies Against Hendra And Nipah | Technology Transfer
human monoclonal antibodieshendranipahtechnologytransfer
https://www.techtransfer.nih.gov/patent/e-047-2022-0-my-01
Human Monoclonal Antibodies That Broadly Target Coronaviruses | Technology Transfer
human monoclonal antibodiesbroadlytargetcoronavirusestechnology
https://www.techtransfer.nih.gov/patent/e-162-2014-0-jp-05
HUMAN MONOCLONAL ANTIBODIES AGAINST EPHA4 AND THEIR USE | Technology Transfer
human monoclonal antibodiesusetechnologytransfer
https://www.techtransfer.nih.gov/patent/e-217-2005-2-au-02
Human Monoclonal Antibodies That Specifically Bind IGF-II. | Technology Transfer
human monoclonal antibodiesspecificallybindigfii
https://pmc.ncbi.nlm.nih.gov/articles/PMC18751/
Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of...
Promoting remyelination, a major goal of an effective treatment for demyelinating diseases, has the potential to protect vulnerable axons, increase conduction...
human monoclonal antibodies
https://www.techtransfer.nih.gov/patent/e-162-2014-0-nl-25
HUMAN MONOCLONAL ANTIBODIES AGAINST EPHA4 AND THEIR USE | Technology Transfer
human monoclonal antibodiesusetechnologytransfer
https://www.techtransfer.nih.gov/patent/e-014-2017-0-us-01
Human Monoclonal Antibodies Against FLT3 and Uses Thereof | Technology Transfer
human monoclonal antibodiesusestechnologytransfer
https://cvvr.hms.harvard.edu/publication/cross-neutralizing-activity-of-human-anti-v3-monoclonal-antibodies-derived-from-non-clade-b-hiv-1-infected-individuals/
Cross-neutralizing activity of human anti-V3 monoclonal antibodies derived from non-clade B HIV-1...
https://pmc.ncbi.nlm.nih.gov/articles/PMC7873987/
Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications...
We sought to determine whether immune reactivity occurs between anti-SARS-CoV-2 protein antibodies and human tissue antigens, and whether molecular mimicry...
https://www.techtransfer.nih.gov/patent/e-144-2002-1-us-01
Identification of Novel Broadly Cross-Reactive HIV 1 Neutralizing Human Monoclonal Antibodies |...